TIGIT and clear cell renal carcinoma: Johnston et al. [45] had previously demonstrated that TIGIT was significantly upregulated in tumor-infiltrating lymphocytes in endometriosis, breast cancer, clear cell renal cell carcinoma, non-small cell lung cancer, and colorectal cancer.